Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02016729 |
| Title | A Phase 1b Study Evaluating AMG 232 Alone and in Combination With Trametinib in Acute Myeloid Leukemia |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Amgen |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Research Site | Birmingham | Alabama | 35294 | United States | Details | |
| Research Site | Buffalo | New York | 14263 | United States | Details | |
| Research Site | Charlotte | North Carolina | 28204 | United States | Details | |
| Research Site | Salt Lake City | Utah | 84112 | United States | Details | |
| Research Site | Seattle | Washington | 98101 | United States | Details |